Suchergebnisse - "Amiri, Mohammad Mehdi"

PubPharm (6)

1

Comparative Immunogenicity and Neutralization Potency of Four Approved COVID-19 Vaccines in BALB/c Mice

enthalten in: Iranian journal of immunology : IJI | 2024

von Dashti, N. | Golsaz-Shirazi, F. | Jeddi-Tehrani, M. | +3

2

Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain

enthalten in: Journal of medical microbiology | 2023

von Ghorbani, A. | Maghsood, F. | Yadegari, H. | +6

3

Epitope mapping of neutralising anti-SARS-CoV-2 monoclonal antibodies : Implications for immunotherapy and vaccine design

enthalten in: Reviews in medical virology | 2022

von Ghotloo, S. | Maghsood, F. | Golsaz-Shirazi, F. | +3

4

Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization

enthalten in: Neurotoxicity research | 2020

von Ghotloo, S. | Amiri, M. | Khoshnoodi, J. | +4

5

Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)

enthalten in: Antiviral research | 2017

von Golsaz-Shirazi, F. | Amiri, M. | Farid, S. | +11

6

Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection

enthalten in: Journal of gastroenterology and hepatology | 2014

von Golsaz Shirazi, F. | Mohammadi, H. | Amiri, M. | +8

1
[1]